{"id":"W2152163581","doi":"10.1093/brain/awv029","title":"Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage","year":2015,"lang":"en","type":"article","venue":"Brain","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; University of California, San Diego; Genentech; National Institutes of Health; IXICO; Servier; Innovative Medicines Initiative; Center for Translational Molecular Medicine; Eisai; National Institute on Aging; National Institute for Health and Care Research; Northern California Institute for Research and Education; Alzheimer Nederland; Pfizer; Biogen; BioClinica; F. Hoffmann-La Roche; Synarc; University of Southern California; European Federation of Pharmaceutical Industries and Associations; Medpace; Novartis Pharmaceuticals Corporation; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; European Commission; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Alzheimer's Association; Stichting Dioraphte; Foundation for the National Institutes of Health","keywords":"Cognitive impairment; Disease; Alzheimer's disease; Stage (stratigraphy); Prodromal Stage; Medicine; Dementia; Cognition; Gerontology; Psychology; Psychiatry; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05693348160569533,"score_gpt":0.3529009080350215,"score_spread":0.2959674264293262,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}